Eupraxia 制药 EPRX
$6.89 +$0.29 (+4.39%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.89 0.00%
开盘$6.60
昨收$6.60
当日区间$6.52 – $6.89
成交量585.1K
市值$455.25M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$18.10M-119.1% YoY
净利润-$14.49M-65.7% YoY
摊薄每股收益-$0.23+11.4% YoY
自由现金流-$13.27M-56.4% YoY
经营现金流-$13.09M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-111.0%
资产收益率-62.9%
投入资本回报率-111.1%
流动比率16.00
负债/资产比率7.3%
现金及投资$133.66M
总负债$1.68M
净现金（净负债）$131.98M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $18.10M | $15.96M | $38.43M | $16.16M | $6.88M |
| 销售及管理费用 | $5.30M | $4.78M | $17.10M | $8.30M | $2.47M |
| -管理费用 | $5.30M | $4.78M | $17.10M | $8.30M | $2.47M |
| 研发费用 | $12.81M | $11.17M | $21.33M | $7.87M | $4.42M |
| 营业利润 | -$18.10M | -$15.96M | -$38.43M | -$16.16M | -$6.88M |
| 非经营性利息净收入（支出） | $1.39M | $1.07M | $1.41M | $666,921.00 | $180,185.00 |
| 非经营性利息收入 | $1.39M | $1.07M | $1.41M | $666,921.00 | $180,185.00 |
| 其他收入（支出） | $2.25M | $2.24M | -$1.57M | -$1.21M | $332,934.00 |
| 证券出售收益 | $2.25M | $2.24M | -$1.56M | -$1.21M | $332,934.00 |
| 特殊收益（费用） | -$2,704.00 | $0.00 | -$2,562.00 | -$1,487.00 | $0.00 |
| -固定资产出售收益 | -$2,704.00 | $0.00 | -$2,562.00 | -$1,487.00 | $0.00 |
| 税前利润 | -$14.46M | -$12.64M | -$38.59M | -$16.71M | -$6.37M |
| 税费 | $30,381.00 | $13,905.00 | $19,091.00 | $11,339.00 | -$623.00 |
| 净利润 | -$14.49M | -$12.65M | -$38.61M | -$16.72M | -$6.37M |
| 持续经营利润 | -$14.49M | -$12.65M | -$38.61M | -$16.72M | -$6.37M |
| 少数股东权益 | -$6,478.00 | -$1,415.00 | -$29,509.00 | -$10,084.00 | -$7,991.00 |
| 归属母公司净利润 | -$14.49M | -$12.65M | -$38.58M | -$16.71M | -$6.36M |
| 优先股股息 | $596,050.00 | – | – | – | – |
| 归属普通股股东净利润 | -$15.08M | -$12.65M | -$38.58M | -$16.71M | -$6.36M |
| 基本每股收益 | -$0.23 | -$0.23 | -$1.03 | -$0.37 | -$0.19 |
| 摊薄每股收益 | -$0.23 | -$0.23 | -$1.03 | -$0.37 | -$0.19 |
| 非经营性利息支出 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $139.91M | $145.35M | $86.15M | $86.15M | $92.35M |
| 流动资产合计 | $136.80M | $142.13M | $85.10M | $85.10M | $91.40M |
| 现金及现金等价物与短期投资 | $133.66M | $138.88M | $80.56M | $80.56M | $88.96M |
| -现金及现金等价物 | $52.43M | $58.50M | $80.56M | $80.56M | $88.96M |
| -短期投资 | $81.23M | $80.38M | – | – | – |
| 应收款 | $688,219.00 | $663,235.00 | $674,226.00 | $674,226.00 | $139,904.00 |
| -应收税款 | $688,219.00 | $663,235.00 | $674,226.00 | $674,226.00 | $139,904.00 |
| 预付资产 | $2.46M | $2.58M | $3.86M | $3.86M | $2.30M |
| 非流动资产合计 | $3.10M | $3.23M | $1.05M | $1.05M | $949,192.00 |
| 固定资产净值 | $3.05M | $3.17M | $987,126.00 | $987,126.00 | $851,595.00 |
| -固定资产原值 | $3.81M | $3.86M | $1.63M | $1.63M | $1.44M |
| -累计折旧 | -$756,638.00 | -$693,467.00 | -$644,167.00 | -$644,167.00 | -$584,869.00 |
| 一年以上预付资产 | $53,702.00 | $61,754.00 | $64,332.00 | $64,332.00 | $97,597.00 |
| 负债合计 | $10.23M | $9.17M | $5.70M | $5.70M | $3.91M |
| 流动负债合计 | $8.55M | $7.36M | $5.63M | $5.63M | $3.81M |
| 应付款 | $1.10M | $468,451.00 | $1.52M | $1.52M | – |
| -应付税款合计 | $21,184.00 | $23,390.00 | $1,606.00 | $1,606.00 | – |
| -其他应付款 | $1.08M | $445,061.00 | $1.52M | $1.52M | – |
| 一年内应计费用 | $7.29M | $6.69M | $4.03M | $4.03M | $3.73M |
| 短期债务及融资租赁负债 | $159,877.00 | $203,510.00 | $78,452.00 | $78,452.00 | $76,136.00 |
| -一年内到期融资租赁负债 | $159,877.00 | $203,510.00 | $78,452.00 | $78,452.00 | $76,136.00 |
| 非流动负债合计 | $1.68M | $1.80M | $75,910.00 | $75,910.00 | $94,467.00 |
| 长期债务及融资租赁负债 | $1.68M | $1.80M | $75,910.00 | $75,910.00 | $94,467.00 |
| -长期融资租赁负债 | $1.68M | $1.80M | $75,910.00 | $75,910.00 | $94,467.00 |
| 股东权益合计 | $129.67M | $136.19M | $80.45M | $80.45M | $88.44M |
| 股东权益 | $131.28M | $137.78M | $82.04M | $82.04M | $90.03M |
| 股本 | $293.70M | $285.24M | $225.15M | $225.15M | $222.72M |
| -普通股 | $264.18M | $255.50M | $195.41M | $195.41M | $191.02M |
| -优先股 | $29.52M | $29.74M | $29.74M | $29.74M | $31.71M |
| 资本公积 | $41.31M | $39.27M | $28.52M | $28.52M | $23.47M |
| 留存收益 | -$196.72M | -$182.23M | -$169.58M | -$169.58M | -$152.87M |
| 不影响留存收益的损益 | -$7.01M | -$4.48M | -$2.04M | -$2.04M | -$3.30M |
| 少数股东权益 | -$1.60M | -$1.60M | -$1.60M | -$1.60M | -$1.59M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$13.09M | -$10.15M | -$28.55M | -$9.73M | -$4.51M |
| 持续经营经营活动现金流净额 | -$13.09M | -$10.15M | -$28.55M | -$9.73M | -$4.51M |
| 持续经营净利润 | -$14.49M | -$12.65M | -$38.61M | -$16.72M | -$6.37M |
| 持续经营损益 | -$2.24M | -$2.23M | $1.57M | $1.19M | -$328,491.00 |
| 折旧、折耗与摊销 | $134,935.00 | $90,146.00 | $237,717.00 | $72,806.00 | $62,993.00 |
| 其他非现金项目 | -$907,891.00 | -$408,712.00 | -$76,945.00 | -$18,589.00 | -$18,922.00 |
| 营运资金变动 | $1.38M | $2.80M | -$713,700.00 | -$231,592.00 | $1.70M |
| -应收款变动 | -$26,168.00 | $23,964.00 | -$431,449.00 | -$528,267.00 | -$7,278.00 |
| -预付资产变动 | $49,457.00 | $1.24M | -$2.64M | -$1.47M | $556,374.00 |
| -应付账款及应计费用变动 | $1.35M | $1.54M | $2.36M | $1.76M | $1.15M |
| 投资活动现金流净额 | -$173,092.00 | -$80.05M | -$588,947.00 | -$193,301.00 | -$60,377.00 |
| 持续经营投资活动现金流净额 | -$173,092.00 | -$80.05M | -$588,947.00 | -$193,301.00 | -$60,377.00 |
| 固定资产购置及出售净额 | -$173,092.00 | -$326,953.00 | -$588,947.00 | -$193,301.00 | -$60,377.00 |
| 投资购置及出售净额 | $0.00 | -$79.72M | – | – | – |
| 筹资活动现金流 | $7.48M | $68.58M | $76.06M | $1.49M | $73.90M |
| 持续经营筹资活动现金流净额 | $7.48M | $68.58M | $76.06M | $1.49M | $73.90M |
| 普通股发行净额 | -$9.27M | $58.63M | $73.89M | $0.00 | $73.89M |
| 股票期权行使所得 | $16.75M | $9.95M | $2.17M | $1.49M | $6,785.00 |
| 期末现金余额 | $52.43M | $58.50M | $80.56M | $80.56M | $88.96M |
| 现金净变动 | -$5.79M | -$21.62M | $46.92M | -$8.43M | $69.33M |
| 期初现金余额 | $58.50M | $80.56M | $33.10M | $88.96M | $19.77M |
| 汇率变动影响 | -$283,988.00 | -$448,176.00 | $544,813.00 | $33,894.00 | -$137,324.00 |
| 自由现金流 | -$13.27M | -$10.47M | -$29.14M | -$9.92M | -$4.57M |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 EPRX。
登录后参与讨论。